Argentina vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
Argentina
0
in 2020
New Zealand
0.1
in 2020
Argentina rank
13th
New Zealand rank
11th
Proportion of isolates with decreased susceptibility or resistance over time
- Argentina
- New Zealand
How they compare
New Zealand currently reports 0.1 against 0 in Argentina, a difference of 0.1.
Across all 10 years both countries report, New Zealand has been ahead every year.
Argentina ranks 13th and New Zealand ranks 11th of 52 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 0.0184 | 0.3595 | 0.3411 | New Zealand |
| 2020s | 0 | 0.1 | 0.1 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Argentina or New Zealand?
- New Zealand, at 0.1 against 0 in Argentina as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Argentina and New Zealand?
- 0.1, with New Zealand ahead.
- How many years of comparable data are there for Argentina and New Zealand?
- 10 years are reported by both, from 2009 to 2020.
- How do Argentina and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- Argentina ranks 13th and New Zealand ranks 11th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.